• Latest Posts
More News! 29 Sep 2022

Removing binding sites for an oncogene can slow cancer cell growth, researchers say

Scribe Therapeutics enters into agreement with Sanofi for use of its CRISPR technologies

Scope Biosciences and WUR to improve CRISPR-Cas technology with new funds

CRISPR/CAS9 strategic alliance between Sigma-Aldrich and genOway expanded

Beyond Biotech podcast 11: Ilya Pharma, IRB Barcelona, Krystal Biotech, Phase Genomics

Gene therapies for lung cancer identified by international team of scientists

ADVERTISEMENT

Study says gene editing with CRISPR/Cas9 can lead to cell toxicity and genome instability

Deciphering the molecular mechanisms of severe COVID-19

SNIPR Biome announces new patent granted for applications targeting E. coli infections

Opinion 16 May 2022

CRISPR Can Help The Switch To Sustainable Cosmetics

UK Startup Lands €5M Seed Round to Produce Gene-Edited Crops with AI

ADVERTISEMENT